CD44 and breast carcinoma: Additionally, AMPK-triggered nuclear translocation of GAPDH leads to Sirt-1 release from the complex deleted in breast cancer-1 (DBC-1), an inhibitor of Sirt-1, thereby enhancing Sirt-1 transcriptional activity [25].